Nanoparticles releasing zoledronic acid have antitumor activity against experimental models of human glioblastoma

被引：0
|
作者：
Leonetti, C. [1 ]
Porru, M. [1 ]
Artuso, S. [1 ]
Zappavigna, S. [2 ]
Luce, A. [2 ]
Salzano, G. [3 ]
Lusa, S. [3 ]
De Rosa, G. [3 ]
Caraglia, M. [2 ]
机构：
[1] Regina Elena Inst Canc Res, Expt Chemotherapy Lab, Rome, Italy
[2] Univ Naples 2, Dept Biochem & Biophys, Naples, Italy
[3] Univ Naples Federico II, Dept Chem & Pharmaceut Chem Toxicol, Naples, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3367
引用
收藏
页码：S794 / S795
页数：2
相关论文
共 50 条
  • [41] Research on the synthesis of nanoparticles of betulinic acid and their targeting antitumor activity
    Chen, Xuan
    Lu, Shuting
    Gong, Fengrong
    Sui, Xiaoyu
    Liu, Tingting
    Wang, Ting
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 2022, 110 (08) : 1789 - 1795
  • [42] Evaluation of antitumor activity of benzimidazole derivative on models of experimental tumors
    Kit, O. I.
    Verenikina, E. V.
    Maksimov, A. Y.
    Goncharova, A. S.
    Kurbanova, L. Z.
    Khodakova, D. V.
    Pandova, O. V.
    Zaikina, E. V.
    Komarova, E. F.
    Morkovnik, A. S.
    Zhukovskaya, O. N.
    Shevchenko, N. A.
    Vlasov, S. N.
    YAKUT MEDICAL JOURNAL, 2022, (01): : 23 - 26
  • [43] Potent antitumor activity of zoledronic acid-induced Vγ9Vδ2 T cells against primary effusion lymphoma
    Goto, Hirold
    Matsuda, Kould
    Srikoon, Pattaravadee
    Kariya, Ryusho
    Hattori, Shinichiro
    Taura, Manabu
    Katano, Harutaka
    Okada, Seiji
    CANCER LETTERS, 2013, 331 (02) : 174 - 182
  • [44] Antitumor activity of a novel small molecule agent PRLX 93936 against human tumor xenograft models
    Robbins, Paul
    Clemens, Chris
    Pierce, Michael
    Peltier, John
    Selliah, Robert
    Venkat, Raj Gopal
    Rebentisch, Matt
    Lai, Shuping
    Becklin, Robert
    Senina, Anna
    O'Mel, Vlad
    Erkkila, Tracy
    Sahasrabudhe, Sudhir R.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3444S - 3444S
  • [45] Mechanisms of the Antitumor Activity of Human Vγ9Vδ2 T Cells in Combination With Zoledronic Acid in a Preclinical Model of Neuroblastoma
    Di Carlo, Emma
    Bocca, Paola
    Emionite, Laura
    Cilli, Michele
    Cipollone, Giuseppe
    Morandi, Fabio
    Raffaghello, Lizzia
    Pistoia, Vito
    Prigione, Ignazia
    MOLECULAR THERAPY, 2013, 21 (05) : 1034 - 1043
  • [46] Selenium nanoparticles (SeNPs) have potent antitumor activity against prostate cancer cells through the upregulation of miR-16
    Liao Guolong
    Tang Jiani
    Wang Di
    Zuo Haoru
    Zhang Qi
    Liu Ying
    Xiong Haiyun
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)
  • [47] Selenium nanoparticles (SeNPs) have potent antitumor activity against prostate cancer cells through the upregulation of miR-16
    Guolong Liao
    Jiani Tang
    Di Wang
    Haoru Zuo
    Qi Zhang
    Ying Liu
    Haiyun Xiong
    World Journal of Surgical Oncology, 18
  • [48] Molecular and preclinical models enhancing anti-tumour activity of zoledronic acid
    Marra, M.
    Santini, D.
    Tonini, G.
    Meo, G.
    Zappavigna, S.
    Facchini, G.
    Morabito, A.
    Abbruzzese, A.
    Carteni, G.
    Budillon, A.
    Caraglia, M.
    EJC SUPPLEMENTS, 2008, 6 (14): : 79 - 85
  • [49] Antitumor Effects of 5-Aminolevulinic Acid on Human Malignant Glioblastoma Cells
    Jalili-Nik, Mohammad
    Abbasinezhad-moud, Farzaneh
    Sahab-Negah, Sajad
    Maghrouni, Abolfazl
    Etezad Razavi, Mohammad
    Khaleghi Ghadiri, Maryam
    Stummer, Walter
    Gorji, Ali
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [50] Synergistic antitumor effect of zoledronic acid in combination with HDAC inhibitor LBH589 in human prostate, breast and multiple myeloma tumor models
    Bruzzese, Francesca
    Rocco, Monia
    Pucci, Biagio
    Caraglia, Michele
    Budillon, Alfredo
    CANCER RESEARCH, 2009, 69
12345